Alive
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why, its from 2022.
Why everyone does not have him on ignore is a tell. Some find it a personal ego attack and also believe the false illusion that they MUST respond to his bs, thus their insatiable need to respond. But its all a game the Ex's of these board have mastered, and the responders are the losers in this game. And they lose with every response, but cannot see that. Ignorance, in this case, is bliss.
He made that up or is simply ignorant.
https://www.whitehouse.gov/cancermoonshot/
"In the meantime, Biden’s leaning on the agencies to keep moonshot programs going and pursuing private sector help that costs the government nothing. Last month, he said the country’s largest health insurers were expanding services to help patients and their families navigate health care treatments for cancer."
Jeez, every weekend full of clueless replies to ex and his ilk, as if it does anything but feed the fire. So ignorantly stupid this behavior is...
With the lack of comminication from nwbo, the last thing they want to do is say they got one, thus breaking the silence with a possible negative.
I hope nwbo is paying attention. This is how you role out an acceptance. You tag it with a manufacturing giant, and your stock pops another 13%.
ImmunityBio has signed an exclusive global arrangement with the Serum Institute of India to supply ImmunityBio with Bacillus Calmette-Guerin
16:07:20 PM ET, 05/02/2024 - Briefing.com
Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA, ImmunityBio's recently approved treatment for non-muscle invasive bladder cancer.Serum Institute of India will manufacture both standard BCG and next-generation recombinant BCG, creating a long-term solution to chronic BCG supply shortage issues.Standard BCG from the Serum Institute is currently administered in number of countries worldwide for treatment of NMIBC.Recombinant BCG has demonstrated potent immunogenicity with CD8+ and CD4+ stimulation and improved safety compared to standard BCG in clinical trials across Europe.Collaboration will help to ensure availability of BCG for all approved indications that benefit from ANKTIVA's triangle offense of natural killer cells, T cells, and memory T cells.Global clinical trials planned to study standard of care ANKTIVA plus BCG with globally available sBCG and iBCG from Serum Institute, the QUILT BCG randomized clinical trial.
Ibrx is going to rip up again today. I wonder if there are any combo possibilities with nwbo? Different delivery systems, but on a chemical basis who knows? It's still immunotherapy.
Thanks to German Col for this tip.
I was being (look it up if you have to) facetious.
Sell in May, Make my day?
https://images.app.goo.gl/MqqT142uYvZPoWLQA
Sold 75k nwbo and bought irbx (per GC) at 7.60. Turns out to have been a good move as their succesful cancer trial ACTUALLY MOVED THE STOCK PRICE UP.
That apparently is their plan, enrich themselves and screw the shareholders.
That is 100% true. Longs want to escape the torture of silent non management, and any pop over $2 will trigger a huge selloff as trust is about zero.
They do not care one bit about shareholders, but are focused on dishing out bonuses for being inept. Business as usual for nwbo deaf dumb and silent non management.
I guess inept mis management wants rhe stock to go to .40 and below. Deaf dumb and silent is no way to run a company while treating SH like shit.
Omitting info and zero pr's is business as usual for inept nwbo management. So, your theory might not be true due to the silence and lack of execution that is nwbo.
And management is nowhere to be seen or heard, but will dish out bonuses to each other. Worst run company by inept, but getting richer, non management.
SH have zero control here, and non management could care less, they wont even talk to us. Just keep paying themselves over and over, increasing share count, and saying f&ck u to SH.
With the stock tanking and no communication from non mamangement at all, this is a bad time to discuss bonuses. How about a shareholder bonus??? How about talking to shareholders? How about ASM, submission mistakes, and one fu&king peep out of mis management??????
Yeah, but like Hollywood stories, I hope it has an ending. Inept management has added at least 2 years to the big acceptance myth (so far...)
Knowing that nwbo flunked communication 101, has been hiding heads in the sand for many months now, and will not admit to a flawed submission, August may be a tad early to expect news, and by then were looking more towards 2025...MAYBE. I just cannot understand how this incredibly inept mis management thinks that silence is golden, it ain't. Worst ever lack of company communication, and that usually means they are avoiding admission of mistakes. Face it, management has sucked big time on this and other fronts for at least 10 years now. They surely love to torture the shareholders, and this lack of ANYTHING will certainly lead to a big selloff on any SP increase of $5 or more, maybe even at $3-4. Fucking wearing us all out and losing longs daily.
All the nwbo chartists have been 100% wrong. You'll get better results from a magic 8 ball.
Don't hold you breath. Nwbo's most consistant strength is silence and leaving shareholders in the dark. That's why no updates, no ASM, no nothing but worthless appearences to discuss old news. I wonder if any of this changes in 2024.
Yeah, unlike cvm, here at least we know the data is great. Once the mm's are silenced by news, it should fly. When is the big question. I almost bought ibrx yesterday after checking it out, now sorry I did not.
Thanks for the reply, and lets all make money.
When are we at 150 days from the guessed acceptance of the 1.7 million page submission? May or June? I wonder how many longs think May, June, or July is when we will see news. Over 1 million shares traded today to get us in the green. Weekends have to be hard on the shorts.
That filled fast after a partial fill. Now try 5k for .45.
Just being facetious. In times like this, humor is better than nothing.
So May then. 🤪 Got another 10k bid in at .46, lets getherdone.
Since April was rumored to be a good month, how about some news Tuesday? That would be nice. Otherwise, we slide into a May of more guesses and on and on...
I feel and have been feeling your pain on this stock, thus my lack of faith in management to get anything done on time and even talk to the shareholders. You simply stated what many of us feel, and tomorrow never ever seems to come but keeps getting promised. The lack of transperity, communication, and accountability is the worse I have ever seen in a company I am invested in. That, sadly, is the real truth about nwbo and the clown show it has become due to silence.
Every biotech is succesful except nwbo, the silent unknown company. Some things never seem to change. Management is, as usual, MIA.
It's been the 9th inning for over a year now.
There you go DD, they could have said something according to this paragraph instead of ignoring SH's and going silent with head in ground:
However, companies can share factual, non-promotional information about the product, such as its development status, the progress of the MAA, and general scientific findings that are not directly linked to the promotional claims about the product's benefits or risks. For example, they might inform retailers about the submission of the MAA or general updates on the approval process timeline without making specific claims about the product's potential success or market availability.
I'd be rich if I had a dollar for every time somebody said we are a month or 2 away from news.
Yes, if in May hallelujah!! If not, get more bourbon.
Thats logical, but what is not is silence from management, no pr update or guidance for shareholders, no ASM, no nothing. That is illogical.
My fear is that May brings only more silence from management and no approval. Like April. That would really suck.
Non management staying silent is killing nwbo. Some things never change. Are they silent because they fucked up submission??? Would not suprise me. They really do not know how to communicate.
Silence is the stock killer, and silence is what nwbo management is good at. Another shitty day.
Especially with supposed good news coming. Another bloodbath on the way down the .40's.